Adicet Therapeutics
5 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1 Study of ADI-001 in Rheumatoid Arthritis (NCT07100873) | Adicet Therapeutics | 2025-10-10 |
| A Phase 1/2 Trial of ADI-270 in ccRCC (NCT06480565) | Adicet Therapeutics | 2024-12-12 |
| A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease (NCT06375993) | Adicet Therapeutics | 2024-11-10 |
| Long-term Follow-up Study of Allogeneic Gamma Delta (γδ) CAR T Cells (NCT04911478) | Adicet Therapeutics | 2022-02-14 |
| A Phase 1 Study of ADI-001 in B Cell Malignancies (NCT04735471) | Adicet Therapeutics | 2021-03-04 |
Track Adicet Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.